Minerva Neurosciences to Participate in Two Upcoming Investor Conferences
Globe Newswire•28/08/2026•08:00 ET
0
Whiz Insights
BURLINGTON, Mass., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that management will participate in two upcoming investor conferences.
Wells Fargo Healthcare Conference Date: Tuesday, September 8 Format: 1x1 meetings Location: New York, NY
Get started
Create a free account to read the full story.